Intelligent volume-assured pressure support (iVAPS) is new noninvasive ventilation (NIV) modes can automatically adjust pressure support to deliver effective ventilation.The objectives are to compare treatment efficacy and level of satisfaction between auto-titrating expiratory positive airway pressure (Auto EPAP) and fixed (Fixed-EPAP) during (iVAPS) treatment in stable hypercapnic chronic obstructive pulmonary disease (COPD) patients.Patients & methods:In this prospective single-blinded, randomized study, 50 patients with chronic stable hypercapnic (COPD) who met the study criteria; patients were randomized into group I treated with Auto-EPAP and group II who received Fixed EPAP during iVAPS treatment for 5 consecutive days. Patient's characteristics, Arterial blood gases, and lung function test were recorded. Numeric rating scale (NRS), dyspnea and comfort scale were obtained. The patients were evaluated and followed up after initiating therapy for 5 consecutive days. Outcome measures were recorded at baseline (T0) and after three (T1) and five (T2) days of each consecutive period. All parameters were collected and statistically analyzed.Results: No significant differences were found regarding age, sex, and BMI. It was noted that daytime PaCO2 decreased significantly over the follow-up period in group I patients treated with (Auto-EPAP) as compared with (Fixed EPAP). Regarding patient comfort and dyspnea during iVAPS treatment, dyspnea sensation was significantly lower with Auto –EPAP (7.9±1.8 (T0) vs. 3.5±1.1 (T2), p-=0.001) and Fixed – EPAP (7.7±1.9 (T0) vs. 3.4±1.6 (T2), p=0.001), but no significance was reached between both groups. However, Auto EPAP demonstrated significant improvement in comfort when compared with Fixed-EPAP modality. However, the overall satisfaction in patients receiving Auto EPAP modality was significantly increased. Mean tidal volume tended to be higher in Auto EPAP (698±213 ml) compared with (628±178 ml) in fixed EPAP (P =0.001*). The air leak was significantly lower in auto adjusting mode (2.5 ± 1.3 vs.3.7 ± 2.2 L/ min) in fixed EPAP modality.Conclusion: This new auto-titrating NIV mode may provide additional benefit in decreasing PaCO2 more efficiently and improve patient ̍s comfort and satisfaction.